Amanote Research
Register
Sign In
Puk23 - Evaluation of the Program of Nephroprotection in Patients With Renal Disease of a Colombian Insurance Company
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2821
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
C. Marino
M. Romero
A.M. Cruz
J. Barrera
S. Celis
D. Gallo
Publisher
Elsevier BV
Related search
The Evaluation of the Market Share of an Insurance Company: An Econometric Approach
AFRICAN JOURNAL OF BUSINESS MANAGEMENT
Evaluation of the Exercise Intervention With the “Back School” Education Program in a Brazilian Company of Cigars: A Case Study
Work
Medicine
Environmental
Public Health
Rehabilitation
Occupational Health
Design of the 2009 Evaluation of the Medical Insurance for a New Generation Program
Salud Publica de Mexico
Environmental
Public Health
Occupational Health
An Appraisal of Nephroprotection and the Scope of Natural Products in Combating Renal Disorders
Journal of Nephrology & Therapeutics
Mineral-Bone Disorders in Patients With Chronic Kidney Disease and Diabetes Mellitus: The Real Possibilities of Cardio and Nephroprotection.
Medical Council
Duplex Scanning Has a Limited Role in the Evaluation of Patients With Renal Failure
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Lipoprotein(a) Accelerated the Progression of Atherosclerosis in Patients With End-Stage Renal Disease
BMC Nephrology
Nephrology
Evaluation of Renal Function in Patients With Psoriasis Using Immunobiologicals
Anais Brasileiros de Dermatologia
Dermatology
Condition for the Permissibility of a Lawsuit Against Insurance Company
Anali Pravnog fakulteta u Beogradu
